| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melanoma | 80 | 2024 | 5620 | 7.120 |
Why?
|
| Skin Neoplasms | 30 | 2024 | 5726 | 2.240 |
Why?
|
| Immunotherapy | 32 | 2024 | 4601 | 1.840 |
Why?
|
| Oncolytic Virotherapy | 5 | 2023 | 514 | 1.490 |
Why?
|
| Proto-Oncogene Proteins B-raf | 15 | 2023 | 2035 | 1.010 |
Why?
|
| Drug Resistance, Neoplasm | 19 | 2023 | 5164 | 0.940 |
Why?
|
| Neoplasms, Second Primary | 2 | 2023 | 1051 | 0.910 |
Why?
|
| Oncolytic Viruses | 3 | 2023 | 342 | 0.880 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 2021 | 197 | 0.870 |
Why?
|
| Tumor Microenvironment | 17 | 2024 | 3755 | 0.760 |
Why?
|
| Neoplasms | 17 | 2024 | 21806 | 0.660 |
Why?
|
| Sarcopenia | 1 | 2023 | 366 | 0.630 |
Why?
|
| Protein Kinase Inhibitors | 14 | 2024 | 5594 | 0.630 |
Why?
|
| Sentinel Lymph Node Biopsy | 6 | 2021 | 720 | 0.580 |
Why?
|
| Xenograft Model Antitumor Assays | 11 | 2024 | 3554 | 0.540 |
Why?
|
| CD8-Positive T-Lymphocytes | 11 | 2024 | 4495 | 0.540 |
Why?
|
| Uveal Neoplasms | 3 | 2024 | 334 | 0.510 |
Why?
|
| Immunologic Factors | 2 | 2022 | 1571 | 0.470 |
Why?
|
| MAP Kinase Signaling System | 5 | 2018 | 1480 | 0.470 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2023 | 3600 | 0.470 |
Why?
|
| Neoadjuvant Therapy | 2 | 2024 | 2789 | 0.450 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2024 | 1693 | 0.440 |
Why?
|
| Lymph Node Excision | 3 | 2021 | 1290 | 0.420 |
Why?
|
| Lymphatic Metastasis | 3 | 2017 | 2924 | 0.420 |
Why?
|
| Humans | 127 | 2024 | 752411 | 0.420 |
Why?
|
| Neoplasm, Residual | 3 | 2024 | 994 | 0.410 |
Why?
|
| Women, Working | 1 | 2013 | 87 | 0.400 |
Why?
|
| Neoplasm Staging | 13 | 2024 | 11063 | 0.400 |
Why?
|
| Combined Modality Therapy | 7 | 2024 | 8539 | 0.400 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2146 | 0.390 |
Why?
|
| Single-Cell Analysis | 8 | 2024 | 2318 | 0.380 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 4412 | 0.380 |
Why?
|
| Molecular Targeted Therapy | 4 | 2024 | 2782 | 0.370 |
Why?
|
| Patient Participation | 1 | 2019 | 1431 | 0.350 |
Why?
|
| Cell Line, Tumor | 26 | 2024 | 16737 | 0.350 |
Why?
|
| Prognosis | 15 | 2024 | 29337 | 0.350 |
Why?
|
| Object Attachment | 1 | 2013 | 321 | 0.350 |
Why?
|
| MAP Kinase Kinase 1 | 3 | 2021 | 325 | 0.340 |
Why?
|
| Tumor Burden | 4 | 2024 | 1875 | 0.340 |
Why?
|
| Pancreatic Neoplasms | 2 | 2024 | 5288 | 0.330 |
Why?
|
| Parent-Child Relations | 1 | 2013 | 748 | 0.310 |
Why?
|
| Physician's Role | 1 | 2014 | 914 | 0.290 |
Why?
|
| Physicians, Women | 1 | 2013 | 485 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2021 | 8422 | 0.280 |
Why?
|
| Mutation | 15 | 2023 | 29706 | 0.280 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2023 | 9207 | 0.270 |
Why?
|
| Granzymes | 2 | 2018 | 274 | 0.270 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 3203 | 0.260 |
Why?
|
| Adjuvants, Immunologic | 2 | 2022 | 1024 | 0.250 |
Why?
|
| Colonic Neoplasms | 2 | 2018 | 2500 | 0.250 |
Why?
|
| Antigens, Neoplasm | 3 | 2022 | 1989 | 0.250 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2018 | 343 | 0.250 |
Why?
|
| Tissue Adhesions | 1 | 2006 | 217 | 0.240 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2024 | 1417 | 0.240 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2024 | 35 | 0.240 |
Why?
|
| DNA, Mitochondrial | 2 | 2020 | 842 | 0.240 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2018 | 552 | 0.240 |
Why?
|
| Melanoma, Experimental | 2 | 2020 | 557 | 0.240 |
Why?
|
| Caspase 9 | 1 | 2024 | 186 | 0.230 |
Why?
|
| Antigen Presentation | 2 | 2021 | 1237 | 0.230 |
Why?
|
| Colitis | 2 | 2024 | 1216 | 0.230 |
Why?
|
| Immune Evasion | 2 | 2023 | 357 | 0.210 |
Why?
|
| Neural Stem Cells | 2 | 2021 | 876 | 0.210 |
Why?
|
| GPI-Linked Proteins | 1 | 2024 | 465 | 0.210 |
Why?
|
| Fucose | 1 | 2023 | 121 | 0.210 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 3 | 2023 | 1060 | 0.210 |
Why?
|
| Guideline Adherence | 1 | 2012 | 2275 | 0.200 |
Why?
|
| Mice | 30 | 2024 | 80550 | 0.200 |
Why?
|
| Neoplasm Metastasis | 6 | 2024 | 4862 | 0.190 |
Why?
|
| Osteogenesis | 2 | 2007 | 1265 | 0.190 |
Why?
|
| Receptors, CXCR3 | 2 | 2020 | 234 | 0.190 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2021 | 77 | 0.190 |
Why?
|
| Leiomyosarcoma | 2 | 2016 | 426 | 0.190 |
Why?
|
| Nissl Bodies | 1 | 2020 | 16 | 0.190 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 50 | 0.180 |
Why?
|
| Medical Oncology | 3 | 2024 | 2283 | 0.180 |
Why?
|
| Microsatellite Instability | 1 | 2024 | 703 | 0.180 |
Why?
|
| Endopeptidases | 1 | 2024 | 772 | 0.180 |
Why?
|
| Weightlessness | 1 | 2021 | 93 | 0.180 |
Why?
|
| Survival Rate | 5 | 2023 | 12745 | 0.180 |
Why?
|
| Nephritis | 1 | 2021 | 148 | 0.180 |
Why?
|
| Abdomen | 1 | 2006 | 1112 | 0.170 |
Why?
|
| Antigens, Differentiation | 1 | 2022 | 847 | 0.170 |
Why?
|
| Colorectal Neoplasms | 5 | 2024 | 6792 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2021 | 366 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2020 | 105 | 0.170 |
Why?
|
| Transferrin | 1 | 2020 | 284 | 0.170 |
Why?
|
| Cryosurgery | 1 | 2024 | 459 | 0.170 |
Why?
|
| Cysteine | 1 | 2024 | 887 | 0.170 |
Why?
|
| Tumor Escape | 2 | 2020 | 367 | 0.170 |
Why?
|
| Neural Crest | 1 | 2021 | 278 | 0.160 |
Why?
|
| Cancer Vaccines | 2 | 2024 | 1048 | 0.160 |
Why?
|
| Lipogenesis | 1 | 2020 | 209 | 0.160 |
Why?
|
| Female | 41 | 2024 | 386085 | 0.160 |
Why?
|
| Disease Progression | 5 | 2024 | 13405 | 0.160 |
Why?
|
| Retinoid X Receptor gamma | 1 | 2018 | 3 | 0.160 |
Why?
|
| Proteins | 4 | 2018 | 6015 | 0.160 |
Why?
|
| Myeloid Cells | 2 | 2021 | 815 | 0.160 |
Why?
|
| Parents | 1 | 2013 | 3502 | 0.160 |
Why?
|
| Poisson Distribution | 1 | 2020 | 507 | 0.160 |
Why?
|
| Benzimidazoles | 2 | 2021 | 854 | 0.160 |
Why?
|
| Adenoviridae | 1 | 2023 | 1081 | 0.160 |
Why?
|
| Adaptation, Biological | 1 | 2019 | 146 | 0.160 |
Why?
|
| Thionucleosides | 1 | 2018 | 13 | 0.160 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2022 | 1323 | 0.160 |
Why?
|
| Retrospective Studies | 12 | 2023 | 79133 | 0.160 |
Why?
|
| Genes, cdc | 1 | 2018 | 115 | 0.160 |
Why?
|
| T-Lymphocytes | 6 | 2024 | 10035 | 0.160 |
Why?
|
| Animals | 34 | 2024 | 166811 | 0.150 |
Why?
|
| Space Flight | 1 | 2021 | 197 | 0.150 |
Why?
|
| Aged, 80 and over | 13 | 2024 | 58299 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 6 | 2022 | 6137 | 0.150 |
Why?
|
| PPAR gamma | 1 | 2021 | 484 | 0.150 |
Why?
|
| Carcinoma, Merkel Cell | 2 | 2012 | 319 | 0.150 |
Why?
|
| Exanthema | 1 | 2023 | 500 | 0.150 |
Why?
|
| DNA Copy Number Variations | 2 | 2024 | 2007 | 0.150 |
Why?
|
| Deoxyguanosine | 1 | 2018 | 85 | 0.150 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2007 | 1618 | 0.150 |
Why?
|
| Oxidation-Reduction | 2 | 2024 | 2192 | 0.150 |
Why?
|
| Exosomes | 1 | 2022 | 422 | 0.150 |
Why?
|
| Male | 34 | 2024 | 354908 | 0.150 |
Why?
|
| Interleukin-2 | 2 | 2022 | 1868 | 0.150 |
Why?
|
| Melanoma, Amelanotic | 1 | 2017 | 19 | 0.150 |
Why?
|
| Enteric Nervous System | 1 | 2020 | 203 | 0.150 |
Why?
|
| Substrate Specificity | 1 | 2021 | 1785 | 0.140 |
Why?
|
| Receptors, Chemokine | 1 | 2020 | 651 | 0.140 |
Why?
|
| Single-Blind Method | 1 | 2021 | 1573 | 0.140 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 1 | 2017 | 67 | 0.140 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 128 | 0.140 |
Why?
|
| Indoles | 3 | 2020 | 1815 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2022 | 723 | 0.140 |
Why?
|
| Colonic Polyps | 1 | 2021 | 547 | 0.140 |
Why?
|
| Mitochondria | 2 | 2020 | 3556 | 0.140 |
Why?
|
| Cell Differentiation | 6 | 2021 | 11425 | 0.130 |
Why?
|
| Prednisone | 1 | 2021 | 1563 | 0.130 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 1424 | 0.130 |
Why?
|
| Computer Communication Networks | 1 | 1998 | 295 | 0.130 |
Why?
|
| Aged | 19 | 2024 | 166585 | 0.130 |
Why?
|
| Polyethylene Glycols | 1 | 2022 | 1179 | 0.130 |
Why?
|
| Cell Proliferation | 5 | 2021 | 10360 | 0.130 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2020 | 1758 | 0.130 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2024 | 3489 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 4 | 2021 | 9101 | 0.130 |
Why?
|
| Sulfonamides | 3 | 2020 | 1963 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2023 | 4279 | 0.120 |
Why?
|
| Immunomodulation | 1 | 2019 | 543 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2020 | 6501 | 0.120 |
Why?
|
| Signal Transduction | 9 | 2024 | 23234 | 0.120 |
Why?
|
| Drug Synergism | 1 | 2019 | 1735 | 0.120 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 1741 | 0.120 |
Why?
|
| Middle Aged | 20 | 2024 | 217039 | 0.120 |
Why?
|
| Remission Induction | 1 | 2020 | 2368 | 0.120 |
Why?
|
| Wnt Proteins | 4 | 2007 | 720 | 0.120 |
Why?
|
| Vascular Neoplasms | 1 | 2016 | 167 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 2 | 2021 | 1341 | 0.120 |
Why?
|
| Mentors | 1 | 2019 | 653 | 0.120 |
Why?
|
| Mice, SCID | 4 | 2021 | 2617 | 0.110 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2020 | 935 | 0.110 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 1202 | 0.110 |
Why?
|
| Phylogeny | 1 | 2021 | 2755 | 0.110 |
Why?
|
| Chemokines | 3 | 2024 | 957 | 0.110 |
Why?
|
| Interprofessional Relations | 1 | 2019 | 990 | 0.110 |
Why?
|
| Regression Analysis | 1 | 2023 | 6358 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 2995 | 0.110 |
Why?
|
| Brain Neoplasms | 3 | 2023 | 8892 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2024 | 8443 | 0.110 |
Why?
|
| Telomerase | 1 | 2018 | 740 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 1649 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 1119 | 0.110 |
Why?
|
| Tissue and Organ Procurement | 1 | 2020 | 898 | 0.100 |
Why?
|
| Treatment Outcome | 8 | 2024 | 64250 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2017 | 1248 | 0.100 |
Why?
|
| Bone Morphogenetic Proteins | 3 | 2021 | 835 | 0.100 |
Why?
|
| Gene Expression Profiling | 5 | 2024 | 9356 | 0.100 |
Why?
|
| Cholecystitis | 1 | 1993 | 182 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2017 | 1155 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 990 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 1867 | 0.100 |
Why?
|
| Time Factors | 4 | 2021 | 39846 | 0.100 |
Why?
|
| Cross Infection | 1 | 2021 | 1426 | 0.100 |
Why?
|
| Proportional Hazards Models | 2 | 2024 | 12455 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2021 | 4931 | 0.100 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 327 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2019 | 1792 | 0.100 |
Why?
|
| Faculty, Medical | 1 | 2019 | 1178 | 0.090 |
Why?
|
| Boston | 2 | 2021 | 9240 | 0.090 |
Why?
|
| Mice, Inbred NOD | 3 | 2021 | 1809 | 0.090 |
Why?
|
| Muscle, Smooth | 1 | 2015 | 923 | 0.090 |
Why?
|
| Adult | 17 | 2024 | 216927 | 0.090 |
Why?
|
| Chondrogenesis | 2 | 2002 | 239 | 0.090 |
Why?
|
| Lymphocyte Activation | 2 | 2019 | 5412 | 0.090 |
Why?
|
| Quality Control | 1 | 2012 | 825 | 0.090 |
Why?
|
| Lung Neoplasms | 3 | 2024 | 13167 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6479 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 3 | 2020 | 1945 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7400 | 0.080 |
Why?
|
| Mesoderm | 2 | 2002 | 670 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3590 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 1813 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2441 | 0.080 |
Why?
|
| Antineoplastic Agents | 5 | 2021 | 13550 | 0.080 |
Why?
|
| Spheroids, Cellular | 2 | 2023 | 329 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 4271 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2019 | 3668 | 0.080 |
Why?
|
| General Surgery | 1 | 2019 | 1642 | 0.080 |
Why?
|
| Proteome | 1 | 2017 | 1818 | 0.070 |
Why?
|
| Germ-Line Mutation | 1 | 2015 | 1820 | 0.070 |
Why?
|
| Computational Biology | 1 | 2019 | 3492 | 0.070 |
Why?
|
| Mice, Knockout | 5 | 2020 | 14297 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2214 | 0.070 |
Why?
|
| Neoplasm Proteins | 2 | 2018 | 3599 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 5782 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 21717 | 0.070 |
Why?
|
| Flow Cytometry | 3 | 2020 | 5838 | 0.070 |
Why?
|
| Taste | 2 | 2004 | 185 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2020 | 638 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 7295 | 0.070 |
Why?
|
| Genome, Human | 2 | 2020 | 4401 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15143 | 0.060 |
Why?
|
| Uterine Neoplasms | 1 | 2015 | 1444 | 0.060 |
Why?
|
| Cohort Studies | 5 | 2023 | 40980 | 0.060 |
Why?
|
| Stromal Cells | 2 | 2021 | 1317 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2020 | 12739 | 0.060 |
Why?
|
| Disease-Free Survival | 3 | 2022 | 6780 | 0.060 |
Why?
|
| Intensive Care Units | 2 | 2021 | 3697 | 0.060 |
Why?
|
| Oximes | 2 | 2017 | 309 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2022 | 8315 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 2 | 2023 | 1987 | 0.060 |
Why?
|
| Colon | 2 | 2024 | 1780 | 0.060 |
Why?
|
| Positron-Emission Tomography | 2 | 2018 | 6413 | 0.060 |
Why?
|
| Calcification, Physiologic | 1 | 2004 | 168 | 0.060 |
Why?
|
| SOXE Transcription Factors | 1 | 2024 | 73 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2016 | 3474 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2023 | 3122 | 0.060 |
Why?
|
| Monosomy | 1 | 2024 | 52 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2013 | 2028 | 0.060 |
Why?
|
| Immunophenotyping | 2 | 2019 | 1861 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2006 | 15438 | 0.060 |
Why?
|
| Transfection | 2 | 2017 | 5780 | 0.050 |
Why?
|
| Alcoholism | 2 | 2004 | 1936 | 0.050 |
Why?
|
| Cells, Cultured | 4 | 2020 | 18915 | 0.050 |
Why?
|
| Exploratory Behavior | 1 | 2004 | 262 | 0.050 |
Why?
|
| Sucrose | 1 | 2003 | 156 | 0.050 |
Why?
|
| Tumor Necrosis Factors | 1 | 2023 | 101 | 0.050 |
Why?
|
| Luciferases | 1 | 2004 | 717 | 0.050 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2022 | 35 | 0.050 |
Why?
|
| Succinates | 1 | 2022 | 82 | 0.050 |
Why?
|
| Genomics | 2 | 2019 | 5728 | 0.050 |
Why?
|
| RNA | 2 | 2023 | 2700 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2007 | 4474 | 0.050 |
Why?
|
| Lactate Dehydrogenases | 1 | 2022 | 27 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 2868 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2023 | 184 | 0.050 |
Why?
|
| Retroviridae | 1 | 2004 | 850 | 0.050 |
Why?
|
| Sweetening Agents | 1 | 2004 | 289 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2021 | 2515 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 248 | 0.050 |
Why?
|
| Registries | 1 | 2017 | 8367 | 0.050 |
Why?
|
| Adenocarcinoma | 2 | 2024 | 6304 | 0.050 |
Why?
|
| Apoptosis | 3 | 2021 | 9429 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2023 | 17958 | 0.050 |
Why?
|
| Neurons | 1 | 2020 | 9353 | 0.050 |
Why?
|
| Vancomycin | 1 | 2024 | 498 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2017 | 3766 | 0.050 |
Why?
|
| Endoplasmic Reticulum, Rough | 1 | 2020 | 21 | 0.050 |
Why?
|
| Fathers | 1 | 2003 | 367 | 0.050 |
Why?
|
| Cell Compartmentation | 1 | 2021 | 385 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 17647 | 0.050 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2020 | 59 | 0.050 |
Why?
|
| Telemedicine | 1 | 1998 | 2951 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2020 | 4220 | 0.040 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2020 | 118 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2024 | 3668 | 0.040 |
Why?
|
| Imidazoles | 2 | 2017 | 1175 | 0.040 |
Why?
|
| Hematologic Tests | 1 | 2021 | 236 | 0.040 |
Why?
|
| Food Preferences | 1 | 2003 | 398 | 0.040 |
Why?
|
| Risk Factors | 4 | 2021 | 73425 | 0.040 |
Why?
|
| Censuses | 1 | 2021 | 200 | 0.040 |
Why?
|
| Eye Enucleation | 1 | 2020 | 128 | 0.040 |
Why?
|
| Stem Cells | 2 | 2023 | 3523 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2012 | 10172 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2006 | 1149 | 0.040 |
Why?
|
| beta Catenin | 3 | 2017 | 1041 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2023 | 1988 | 0.040 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2023 | 882 | 0.040 |
Why?
|
| Caspases | 1 | 2023 | 879 | 0.040 |
Why?
|
| Simplexvirus | 1 | 2023 | 803 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2021 | 23788 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2004 | 1151 | 0.040 |
Why?
|
| Vimentin | 1 | 2020 | 256 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2017 | 3597 | 0.040 |
Why?
|
| Young Adult | 3 | 2021 | 57632 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2024 | 1017 | 0.040 |
Why?
|
| Trachea | 1 | 2004 | 1081 | 0.040 |
Why?
|
| Transposases | 1 | 2019 | 103 | 0.040 |
Why?
|
| Cell Cycle Proteins | 2 | 2022 | 3435 | 0.040 |
Why?
|
| Lithium | 1 | 2002 | 598 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2024 | 3029 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2022 | 945 | 0.040 |
Why?
|
| Communication | 1 | 2013 | 3806 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 699 | 0.040 |
Why?
|
| Incidence | 3 | 2023 | 21157 | 0.040 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 11008 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2023 | 1694 | 0.040 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2018 | 65 | 0.040 |
Why?
|
| Interferons | 1 | 2022 | 700 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2021 | 427 | 0.040 |
Why?
|
| Circadian Clocks | 1 | 2020 | 162 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2021 | 716 | 0.040 |
Why?
|
| PPAR alpha | 1 | 2019 | 176 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 52 | 0.040 |
Why?
|
| Membrane Proteins | 3 | 2024 | 7808 | 0.040 |
Why?
|
| Teleradiology | 1 | 1998 | 53 | 0.040 |
Why?
|
| Ileum | 1 | 2020 | 557 | 0.040 |
Why?
|
| Remission, Spontaneous | 1 | 2018 | 382 | 0.040 |
Why?
|
| Telecommunications | 1 | 1998 | 80 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2022 | 851 | 0.040 |
Why?
|
| Sulfones | 1 | 2020 | 443 | 0.040 |
Why?
|
| Adaptor Protein Complex sigma Subunits | 1 | 2017 | 9 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 9467 | 0.040 |
Why?
|
| Melanocytes | 1 | 2021 | 511 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2018 | 256 | 0.040 |
Why?
|
| Ribosomes | 1 | 2020 | 492 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2017 | 202 | 0.040 |
Why?
|
| Multigene Family | 1 | 2020 | 1075 | 0.040 |
Why?
|
| Ligands | 1 | 2024 | 3274 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2022 | 2221 | 0.040 |
Why?
|
| beta 2-Microglobulin | 1 | 2017 | 319 | 0.040 |
Why?
|
| Biopsy | 2 | 2020 | 6743 | 0.030 |
Why?
|
| Efficiency | 1 | 2000 | 475 | 0.030 |
Why?
|
| Acetanilides | 1 | 2018 | 169 | 0.030 |
Why?
|
| Clone Cells | 1 | 2020 | 1653 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 719 | 0.030 |
Why?
|
| Inflammation | 3 | 2021 | 10696 | 0.030 |
Why?
|
| Organoids | 1 | 2023 | 716 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 1689 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2017 | 194 | 0.030 |
Why?
|
| Arginine | 1 | 2020 | 927 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2022 | 1334 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 1820 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2020 | 594 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 3706 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2021 | 1142 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2004 | 2930 | 0.030 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2017 | 159 | 0.030 |
Why?
|
| Cell Death | 1 | 2021 | 1664 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2014 | 5279 | 0.030 |
Why?
|
| United States | 4 | 2024 | 71438 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2000 | 754 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 20840 | 0.030 |
Why?
|
| Apyrase | 1 | 2018 | 369 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 1615 | 0.030 |
Why?
|
| Intestinal Diseases | 1 | 2020 | 503 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2021 | 711 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 444 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2018 | 262 | 0.030 |
Why?
|
| Radiology Information Systems | 1 | 2000 | 523 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 1687 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2020 | 1222 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2024 | 2471 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2002 | 1003 | 0.030 |
Why?
|
| Trans-Activators | 2 | 2002 | 2851 | 0.030 |
Why?
|
| Cofilin 2 | 1 | 2015 | 12 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 993 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2017 | 659 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2020 | 1774 | 0.030 |
Why?
|
| Glycolysis | 1 | 2019 | 826 | 0.030 |
Why?
|
| Pyrimidinones | 1 | 2017 | 381 | 0.030 |
Why?
|
| Desmin | 1 | 2015 | 100 | 0.030 |
Why?
|
| Germ Cells | 1 | 2019 | 632 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2018 | 797 | 0.030 |
Why?
|
| Neuroglia | 1 | 2020 | 940 | 0.030 |
Why?
|
| Wound Healing | 1 | 2006 | 2773 | 0.030 |
Why?
|
| Base Sequence | 2 | 2019 | 12432 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 695 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2004 | 2902 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 2020 | 829 | 0.030 |
Why?
|
| Epitopes | 1 | 2021 | 2496 | 0.030 |
Why?
|
| Interleukins | 1 | 2019 | 773 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 2899 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2002 | 1600 | 0.030 |
Why?
|
| Cytokines | 2 | 2020 | 7235 | 0.030 |
Why?
|
| Cell Lineage | 2 | 2019 | 2513 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2004 | 2613 | 0.030 |
Why?
|
| Phenotype | 2 | 2022 | 16443 | 0.030 |
Why?
|
| Genome | 1 | 2022 | 1739 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1768 | 0.030 |
Why?
|
| Confidentiality | 1 | 1998 | 611 | 0.030 |
Why?
|
| Precipitating Factors | 1 | 1993 | 52 | 0.030 |
Why?
|
| Doxycycline | 1 | 2015 | 328 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1712 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 550 | 0.030 |
Why?
|
| Cholangiography | 1 | 1993 | 182 | 0.030 |
Why?
|
| Protein Transport | 1 | 2018 | 1964 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 870 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 11884 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2002 | 1859 | 0.030 |
Why?
|
| Glycogen Synthase Kinases | 2 | 2002 | 40 | 0.030 |
Why?
|
| Pyridones | 1 | 2017 | 766 | 0.030 |
Why?
|
| Quinolines | 1 | 2017 | 749 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2024 | 15647 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1228 | 0.030 |
Why?
|
| Point Mutation | 1 | 2017 | 1591 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2021 | 7576 | 0.030 |
Why?
|
| Brachytherapy | 1 | 2020 | 1241 | 0.030 |
Why?
|
| Monocytes | 1 | 2021 | 2556 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2014 | 711 | 0.030 |
Why?
|
| Telomere | 1 | 2018 | 919 | 0.020 |
Why?
|
| Genotype | 2 | 2019 | 12869 | 0.020 |
Why?
|
| International Cooperation | 1 | 1998 | 1421 | 0.020 |
Why?
|
| Transgenes | 1 | 2015 | 999 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2018 | 1265 | 0.020 |
Why?
|
| Antibodies | 1 | 2019 | 2412 | 0.020 |
Why?
|
| Europe | 1 | 1998 | 3396 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 507 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2017 | 812 | 0.020 |
Why?
|
| Adenoma | 1 | 2021 | 2141 | 0.020 |
Why?
|
| Models, Biological | 3 | 2019 | 9449 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 1788 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 1993 | 405 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2020 | 2055 | 0.020 |
Why?
|
| Autophagy | 1 | 2018 | 1324 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2021 | 2921 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2023 | 4067 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2002 | 489 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 723 | 0.020 |
Why?
|
| Estradiol | 1 | 2017 | 1938 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2015 | 960 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2002 | 339 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1616 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2018 | 1240 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2002 | 412 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 1660 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 1624 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 6112 | 0.020 |
Why?
|
| Inpatients | 1 | 2021 | 2562 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2017 | 1519 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 4717 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 1882 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 1114 | 0.020 |
Why?
|
| Neutrophils | 1 | 2021 | 3724 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3510 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 2065 | 0.020 |
Why?
|
| Alleles | 1 | 2019 | 6879 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2018 | 3908 | 0.020 |
Why?
|
| Cell Movement | 1 | 2020 | 5172 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 2004 | 3463 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2012 | 887 | 0.020 |
Why?
|
| Drainage | 1 | 1993 | 1153 | 0.020 |
Why?
|
| Cadherins | 2 | 2002 | 904 | 0.020 |
Why?
|
| Frizzled Receptors | 1 | 2007 | 90 | 0.020 |
Why?
|
| Chromatin | 1 | 2019 | 2916 | 0.020 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2007 | 116 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2007 | 272 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2007 | 168 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3359 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 3117 | 0.020 |
Why?
|
| Skin | 1 | 2020 | 4426 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 2 | 2002 | 1344 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2007 | 522 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 1993 | 1117 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 1998 | 3327 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 10196 | 0.020 |
Why?
|
| Proteomics | 1 | 2018 | 3751 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 7996 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2019 | 4715 | 0.010 |
Why?
|
| Me |